Spirometer flow sensor market seen reaching $1.55 billion by 2030

The spirometer flow sensor market is projected to grow from $1 billion in 2025 to $1.55 billion by 2030, driven by rising respiratory disease rates, higher healthcare spending and wider use of remote monitoring. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Spirometer flow sensors are becoming more important as healthcare systems expand respiratory screening, monitoring and home-based care. - The market’s growth signals rising demand for tools that can help detect lung disease earlier and track patient status over time. - Stronger adoption of connected and digital diagnostics could reshape how pulmonary testing is delivered in clinics and at home.

What happened: - The spirometer flow sensor market is projected to rise from $1 billion in 2025 to $1.09 billion in 2026, according to The Business Research Company. - The report forecasts the market will reach $1.55 billion by 2030. - The report puts the market’s 2025-2026 CAGR at 8.8% and the 2026-2030 CAGR at 9.1%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - A spirometer flow sensor measures the volume and speed of air inhaled and exhaled by a person. - The sensor converts airflow variations into electrical signals used to assess respiratory function. - The market’s recent growth is linked to rising chronic respiratory illness rates, wider use of hospital pulmonary function tests, stronger awareness of early lung disease detection, more diagnostic laboratory infrastructure and basic digital spirometry technology. - The forecast period is supported by demand for remote respiratory monitoring, home healthcare and telemedicine, AI-enhanced diagnostic precision, preventive screening programs and connected medical devices. - The report highlights AI-powered respiratory diagnostics, IoT-enabled spirometer sensors, cloud-based pulmonary function testing, portable and handheld devices for home use and higher demand for digital airflow measurement tools in clinical settings. - The rise in respiratory diseases is a major driver because these illnesses affect the lungs and airways and can disrupt breathing and oxygen exchange. - Air pollution is adding pressure by exposing people to fine particulate matter, vehicle emissions and industrial smoke that can damage lung tissue. - In March 2025, the UK Health Security Agency reported a 13% rise in tuberculosis cases in England during 2024, to 5,480 cases from 4,850 in 2023. - Rising healthcare spending is also supporting demand for respiratory diagnostics and other medical devices. - The UK Office for National Statistics said total healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024. - Government-funded healthcare spending in the UK reached $328 billion (£258 billion) in 2024, up 2.5% in real terms from the prior year.

Between the lines: - The market forecast suggests respiratory care is shifting toward more continuous, data-driven monitoring instead of occasional in-person testing. - The emphasis on AI, IoT and cloud platforms points to a broader move toward connected diagnostics across healthcare networks. - North America’s current lead and Asia-Pacific’s growth outlook indicate a mature market in one region and a faster buildout of respiratory testing capacity in another.

What's next: - The report expects remote monitoring, telemedicine and home-use devices to keep driving adoption through 2030. - Preventive screening programs and connected medical devices are likely to play a larger role in demand. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - The spirometer flow sensor market is moving from a niche diagnostic category toward a broader respiratory monitoring platform, with digital and connected tools driving the next leg of growth.